Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Green synthesis of silver nanoparticles using Swertia chirayita and their antioxidant and anticancer potential.

Created on 27 Jun 2026

Authors

Anjali Kerketta, Jasmin Maria James, Alex Yagoo, Jelin Vilvest, A Mariya Vaishnika

Published in

Journal of microencapsulation. Pages 1-14. Jun 27, 2026. Epub Jun 27, 2026.

Abstract

Nanotechnology is widely explored in biomedical fields, especially for cancer therapy and antioxidant applications. Silver nanoparticles (AgNPs) synthesised using plant extracts offer a green and eco-friendly alternative to chemical methods. While AgNPs have been synthesised from many medicinal plants, there are no prior reports on the biosynthesis of AgNPs from the critically endangered Himalayan herb Swertia chirayita, a phytochemical-rich plant containing unique xanthones, iridoids, and secoiridoid glycosides and their application against lung cancer cells. This study reports, for the first time, the biosynthesis of AgNPs using S. chirayita aqueous extract and evaluates their antioxidant and anticancer potential. AgNPs were characterised by UV-Vis, XRD, FESEM, and EDAX. Antioxidant activity was measured by DPPH assay, while cytotoxicity against A549 lung cancer cells was assessed using MTT assay and AO/EtBr staining to observe apoptosis. AgNPs exhibited an IC50 of 40.61 µg/mL, demonstrating strong antioxidant and apoptosis-inducing anticancer effects.

PMID:
42363703
Bibliographic data and abstract were imported from PubMed on 27 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement